At-Home Self-Collection for Pre-Transplant Patients


About this study

The objectives of this study are to determine whether adequate blood volumes can be obtained with the Tasso+ device for anti-HLA antibody testing, to compare MFI levels from at-home collected capillary blood to venous blood, and to obtain user feedback and experiences from patients.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult (≥ 18 years) pre-transplant kidney patient.

Exclusion Criteria:

  • Individuals < 18 years.
  • Not pre-transplant kidney patient.

Eligibility last updated 5/2/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Manish Gandhi, M.D.

Open for enrollment

Contact information:

Makala Amundson

(507) 266-0201

More information


Publications are currently not available